Tamarack Advisers’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,000
| Closed | -$1.34M | – | 44 |
|
|
2023
Q1 | $1.34M | Buy |
+6,000
| New | +$1.34M | 0.49% | 22 |
|
|
2022
Q3 | – | Sell |
-30,000
| Closed | -$7.07M | – | 50 |
|
|
2022
Q2 | $7.07M | Buy |
+30,000
| New | +$7.07M | 4.09% | 8 |
|
|
2022
Q1 | – | Sell |
-15,000
| Closed | -$3.24M | – | 55 |
|
|
2021
Q4 | $3.24M | Sell |
15,000
-50,000
| -77% | -$10.8M | 1.33% | 27 |
|
|
2021
Q3 | $12M | Buy |
65,000
+3,000
| +5% | +$554K | 3.79% | 8 |
|
|
2021
Q2 | $11.1M | Sell |
62,000
-38,000
| -38% | -$6.82M | 3.15% | 13 |
|
|
2021
Q1 | $16.7M | Sell |
100,000
-83,000
| -45% | -$13.9M | 3.43% | 11 |
|
|
2020
Q4 | $28.1M | Buy |
183,000
+23,000
| +14% | +$3.53M | 5.86% | 3 |
|
|
2020
Q3 | $16.2M | Sell |
160,000
-15,000
| -9% | -$1.52M | 4.98% | 6 |
|
|
2020
Q2 | $21.2M | Buy |
175,000
+14,000
| +9% | +$1.69M | 5.9% | 4 |
|
|
2020
Q1 | $15.3M | Buy |
161,000
+9,600
| +6% | +$910K | 5.78% | 7 |
|
|
2019
Q4 | $13.1M | Buy |
151,400
+76,400
| +102% | +$6.61M | 2.99% | 15 |
|
|
2019
Q3 | $5.98M | Buy |
+75,000
| New | +$5.98M | 1.56% | 17 |
|